marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Amneal Pharmaceuticals Financial Ratios 2011-2024 | AMRX
Annual Financial Ratios Amneal Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-13.1 | -1.1 | 50.1 | 10.5 | -1.7 | -9.0 | - | - | - | - | - | - | - |
P/S |
0.4 | 0.1 | 0.3 | 0.4 | 0.4 | 0.9 | - | - | - | - | - | - | - |
EPS |
-0.5 | -0.9 | 0.1 | 0.6 | -2.7 | -0.2 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
949 M | 264 M | 412 M | 368 M | 3.78 B | 4.77 B | 1.64 B | -37.5 M | - | - | - | - | - |
EBITDA per Share |
1.54 | -0.18 | 1.43 | 1.03 | 0.164 | 2.94 | - | - | - | - | - | - | - |
EV/EBITDA |
1.6 | 9.3 | 142.3 | 10.6 | - | - | - | - | - | - | - | ||
PEG |
- | 0.06 | 0.0 | 0.08 | - | - | - | - | - | - | - | ||
P/B |
0.3 | 0.1 | 0.2 | 0.2 | 1.8 | 1.7 | - | - | - | - | - | - | - |
P/CF |
3.0 | 4.5 | 2.7 | 1.9 | -6.4 | 9.9 | - | - | - | - | - | - | - |
ROE % |
-400.71 | -90.67 | 3.59 | 19.65 | -104.36 | -18.93 | - | - | - | - | - | - | - |
ROA % |
-2.28 | -7.12 | 0.33 | 1.69 | -9.87 | -3.90 | - | - | - | - | - | - | - |
ROCE % |
7.91 | -3.03 | 4.71 | 2.74 | -5.95 | 6.22 | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | 2.2 | 2.3 | - | - | - | - | - | - | - |
DSO |
- | - | 55.7 | 113.9 | 142.7 | 124.1 | - | - | - | - | - | - | - |
DIO |
129.0 | 130.4 | 135.0 | 119.7 | 109.2 | 176.3 | - | - | - | - | - | - | - |
DPO |
- | - | 21.1 | 35.2 | 29.5 | 44.3 | - | - | - | - | - | - | - |
Operating Cycle |
129.0 | 130.4 | 190.7 | 233.5 | 251.9 | 300.4 | - | - | - | - | - | - | - |
Cash Conversion Cycle |
129.0 | 130.4 | 169.6 | 198.4 | 222.4 | 256.1 | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Amneal Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | 0.02 | -0.3 | 0.06 | 0.08 | -0.05 | - | -0.02 | -0.8 | -0.01 | - | -0.03 | 0.1 | 0.05 | - | -0.06 | -0.08 | 0.78 | -0.23 | -2.03 | -0.13 | -0.37 | -0.07 | 0.05 | -0.15 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
0.43 | 0.44 | 0.09 | 0.75 | 0.79 | 0.5 | - | 0.59 | -1.04 | 0.43 | - | 0.48 | 0.74 | 0.59 | - | 0.32 | 0.37 | 0.68 | - | -0.57 | 0.12 | -0.5 | - | 0.72 | -1.3 | 65.3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
139.83 | 147.56 | 152.84 | 6.47 | -2.37 | -150.24 | -144.69 | -146.72 | -146.19 | 1.46 | 9.13 | 1.99 | -3.11 | -18.76 | 24.61 | -3.37 | -110.45 | -109.77 | -170.12 | -146.17 | -30.59 | -26.84 | -6.20 | -2.17 | -3.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-2.16 | -1.84 | -2.20 | -0.07 | -0.26 | -6.58 | -6.41 | -6.61 | -6.61 | 0.13 | 0.87 | 0.33 | -0.01 | -1.36 | 1.86 | 0.09 | -6.60 | -6.45 | -10.77 | -9.46 | -2.08 | -2.03 | -0.72 | -0.25 | -0.41 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
10.28 | 9.20 | 6.31 | 5.37 | 6.79 | -2.54 | -4.43 | -3.56 | -4.11 | 4.46 | 4.26 | 4.34 | 3.55 | 1.86 | 2.17 | -1.57 | -5.39 | -6.35 | -7.52 | -5.33 | 0.60 | -4.08 | -1.26 | 4.28 | 7.64 | 16.09 | 8.68 | 8.68 | 3.14 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | 105.4 | - | 110.2 | 100.1 | 110.1 | - | 110.5 | 100.8 | 108.2 | - | 112.3 | 125.5 | 113.8 | 138.8 | 145.8 | 136.3 | 111.0 | 88.3 | 92.2 | 106.2 | - | - | 125.9 | 61.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
123.5 | 115.8 | - | - | 130.0 | 127.5 | - | 140.1 | 132.9 | 141.5 | - | 144.6 | 144.3 | 149.4 | - | 126.7 | 140.1 | 126.8 | - | 129.9 | 117.3 | 123.5 | - | 155.3 | 177.2 | 259.0 | - | 216.5 | 95.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
45.8 | 37.9 | - | - | 33.3 | 36.4 | - | - | - | 18.5 | - | - | - | 23.2 | - | - | - | 15.0 | - | - | - | 16.9 | - | 49.9 | 32.8 | 24.5 | - | 53.4 | 23.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
123.5 | 115.8 | 121.5 | - | 130.0 | 232.8 | - | 250.3 | 233.0 | 251.6 | - | 255.0 | 245.2 | 257.6 | - | 239.0 | 265.5 | 240.6 | 138.8 | 275.7 | 253.6 | 234.5 | 88.3 | 247.6 | 283.4 | 259.0 | - | 342.4 | 156.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
77.7 | 77.9 | 87.4 | - | 96.7 | 196.4 | - | 250.3 | 233.0 | 233.1 | - | 255.0 | 245.2 | 234.5 | - | 239.0 | 265.5 | 225.6 | 138.8 | 275.7 | 253.6 | 217.6 | 88.3 | 197.7 | 250.6 | 234.5 | - | 289.0 | 133.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency